Man Group’s iRadimed IRMD Stock Holding History

Man Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Buy	+15,847	New	+$1.44M	﹤0.01%	1693
2025 Q2	–	Sell	-4,762	Closed	-$250K	–	2279
2025 Q1	$250K	Buy	4,762 +990	+26%	+$55.6K	﹤0.01%	1978
2024 Q4	$207K	Sell	3,772 -10,006	-73%	-$527K	﹤0.01%	1867
2024 Q3	$693K	Buy	13,778 +1,141	+9%	+$52.6K	﹤0.01%	1586
2024 Q2	$555K	Buy	12,637 +6,941	+122%	+$295K	﹤0.01%	1657
2024 Q1	$251K	Sell	5,696 -19,479	-77%	-$861K	﹤0.01%	1969
2023 Q4	$1.2M	Buy	+25,175	New	+$1.06M	﹤0.01%	1398
2023 Q3	–	Sell	-20,629	Closed	-$959K	–	1307
2023 Q2	$985K	Buy	+20,629	New	+$930K	﹤0.01%	1389
2023 Q1	–	Sell	-8,012	Closed	-$291K	–	1657
2022 Q4	$227K	Buy	+8,012	New	+$229K	﹤0.01%	1724

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group's IRMD Position: Q2 2026 in Review

Man Group opened a new position in iRadimed (IRMD) in Q2 2026: 15,847 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #1693 among its holdings. This is a return to the name: Man Group previously reported a position in IRMD as recently as Q1 2025.

Man Group first reported a position in IRMD in Q4 2022 and has held it in 9 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Man Group held 15,847 shares of iRadimed worth $1.51M as of Q2 2026.
iRadimed was a new Man Group position in Q2 2026.
iRadimed made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1693 holding.
Man Group first reported a position in iRadimed in Q4 2022 and has held it in 9 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.